217 related articles for article (PubMed ID: 31109142)
21. Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
J Oral Maxillofac Surg; 2007 Jan; 65(1):17-21. PubMed ID: 17174758
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis-related prognosis in patients with oral squamous cell carcinoma-role of the VEGF +936 C/T polymorphism.
Kämmerer PW; Al-Nawas B; Kalkan S; Liese J; Fruth K; Frerich B; Brieger J
J Oral Pathol Med; 2015 Jul; 44(6):429-36. PubMed ID: 25213013
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and HMGA2.
Ma D; Chen J; Shi Y; Gao H; Wei Z; Fan J; Wang L
Sci Rep; 2024 Apr; 14(1):9616. PubMed ID: 38671227
[TBL] [Abstract][Full Text] [Related]
25. Circulating high mobility group AT-hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma.
Ren W; Gao L; Li F; Qiang C; Li S; Zheng J; Kong X; Deng J; Cai G; Zhang H; Zhou M; Zhi K
J Oral Pathol Med; 2017 Nov; 46(10):998-1003. PubMed ID: 28650082
[TBL] [Abstract][Full Text] [Related]
26. Semaphorin 4A restricts tumor progression by inhibiting angiogenesis of oral squamous cell carcinoma cells.
Liu XQ; Yao Y; Mu JW; Yang FY
Tissue Cell; 2021 Apr; 69():101485. PubMed ID: 33460983
[TBL] [Abstract][Full Text] [Related]
27. Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma.
Ervolino De Oliveira C; Dourado MR; Sawazaki-Calone Í; Costa De Medeiros M; Rossa Júnior C; De Karla Cervigne N; Esquiche León J; Lambert D; Salo T; Graner E; Coletta RD
Int J Oncol; 2020 Jul; 57(1):364-376. PubMed ID: 32377747
[TBL] [Abstract][Full Text] [Related]
28. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
[TBL] [Abstract][Full Text] [Related]
29. Potential Utility of Cell Free High Mobility Group AT-hook 2 (HMGA2) as a Prognostic Biomarker in Liquid Biopsies of Oral Squamous Cell Carcinoma.
Mahmood N; Mushtaq S; Jamal Q; Hanif M; Akhlaq H; Rehman DE; Awan R
Asian Pac J Cancer Prev; 2021 Feb; 22(2):407-412. PubMed ID: 33639654
[TBL] [Abstract][Full Text] [Related]
30. [Significance of a reversal expression of the angiopoietin-1 and 2 in oral squamous cell carcinoma].
Li C; Zhang B; Wang ZH; Chen JC; Li B; Wang SX; Chen J; Li CH; Wang W; Song YF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 May; 44(5):412-8. PubMed ID: 19567053
[TBL] [Abstract][Full Text] [Related]
31. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
[TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of angiopoietin-1 and angiopoietin-2 in oral squamous cell cacinoma].
Li C; Feng HC; Chen JC; Song YF
Ai Zheng; 2005 Nov; 24(11):1388-93. PubMed ID: 16552969
[TBL] [Abstract][Full Text] [Related]
33. Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas.
Li C; Shintani S; Terakado N; Klosek SK; Ishikawa T; Nakashiro K; Hamakawa H
Int J Oral Maxillofac Surg; 2005 Jul; 34(5):559-65. PubMed ID: 16053878
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of SUV39H1 reduces tumor angiogenesis via Notch1 in oral squamous cell carcinoma.
Chen Y; Weng X; Zhang C; Wang S; Wu X; Cheng B
PeerJ; 2024; 12():e17222. PubMed ID: 38650654
[TBL] [Abstract][Full Text] [Related]
35. Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma.
Sasahira T; Kurihara-Shimomura M; Nishiguchi Y; Shimomura H; Kirita T
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455867
[TBL] [Abstract][Full Text] [Related]
36. Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan.
Cheng SJ; Lee JJ; Kok SH; Chou CH; Chang HH; Yang H; Chiang ML; Kuo MY
J Formos Med Assoc; 2011 Jan; 110(1):50-7. PubMed ID: 21316013
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
38. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
[TBL] [Abstract][Full Text] [Related]
39. RUNX3 plays a tumor suppressor role by inhibiting cell migration, invasion and angiogenesis in oral squamous cell carcinoma.
Zhou WN; Du YF; Bai J; Song XM; Zheng Y; Yuan H; Zhang W; Zhang ZD; Wu YN
Oncol Rep; 2017 Oct; 38(4):2378-2386. PubMed ID: 28765934
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of vascular endothelial growth factors A and C in oral squamous cell carcinoma.
Yanase M; Kato K; Yoshizawa K; Noguchi N; Kitahara H; Nakamura H
J Oral Pathol Med; 2014 Aug; 43(7):514-20. PubMed ID: 24762199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]